Corrigendum to “Essential role of Cav3.2 T-type calcium channels in butyrate-induced colonic pain and nociceptor hypersensitivity in mice” [Eur. J. Pharmacol. 887 (2020) 173576] (European Journal of Pharmacology (2020) 887, (S0014299920306683), (10.1016/j.ejphar.2020.173576))

Maho Tsubota, Kazuki Matsui, Maki Nakano, Rie Kajitani, Yuko Ishii, Ken Tomochika, Yuta Nishikawa, Saaya Fukushi, Ayumu Yamagata, Fumiko Sekiguchi, Takuya Okada, Naoki Toyooka, Atsufumi Kawabata*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the published article includes a wrong figure; i.e. Fig. 2 in the published article is an original version before revisions. The updated figure is as below. This mistake occurred in the process of proofreading. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number173795
JournalEuropean Journal of Pharmacology
Volume892
DOIs
StatePublished - 2021/02/05

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Corrigendum to “Essential role of Cav3.2 T-type calcium channels in butyrate-induced colonic pain and nociceptor hypersensitivity in mice” [Eur. J. Pharmacol. 887 (2020) 173576] (European Journal of Pharmacology (2020) 887, (S0014299920306683), (10.1016/j.ejphar.2020.173576))'. Together they form a unique fingerprint.

Cite this